111 related articles for article (PubMed ID: 18157466)
1. Cannabinoids inhibit ATP-activated currents in rat trigeminal ganglionic neurons.
Shen JJ; Liu CJ; Li A; Hu XW; Lu YL; Chen L; Zhou Y; Liu LJ
Sheng Li Xue Bao; 2007 Dec; 59(6):745-52. PubMed ID: 18157466
[TBL] [Abstract][Full Text] [Related]
2. Potentiation by WIN 55,212-2 of GABA-activated currents in rat trigeminal ganglion neurones.
Li ZW; Zhang J; Ouyang CH; Li CY; Zhao FB; Liu YW; Ai YX; Hu WP
Br J Pharmacol; 2009 Dec; 158(8):1904-10. PubMed ID: 19917064
[TBL] [Abstract][Full Text] [Related]
3. Suppression of outward K⁺ currents by WIN55212-2 in rat retinal ganglion cells is independent of CB1/CB2 receptors.
Zhang CQ; Wu HJ; Wang SY; Yin S; Lu XJ; Miao Y; Wang XH; Yang XL; Wang Z
Neuroscience; 2013 Dec; 253():183-93. PubMed ID: 24013008
[TBL] [Abstract][Full Text] [Related]
4. Cannabinoids depress excitatory neurotransmission between the subthalamic nucleus and the globus pallidus.
Freiman I; Szabo B
Neuroscience; 2005; 133(1):305-13. PubMed ID: 15893652
[TBL] [Abstract][Full Text] [Related]
5. Receptor-independent depression of DA and 5-HT uptake by cannabinoids in rat neocortex--involvement of Na(+)/K(+)-ATPase.
Steffens M; Feuerstein TJ
Neurochem Int; 2004 Jun; 44(7):529-38. PubMed ID: 15209421
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of 5-HT(3) receptors-activated currents by cannabinoids in rat trigeminal ganglion neurons.
Shi B; Yang R; Wang X; Liu H; Zou L; Hu X; Wu J; Zou A; Liu L
J Huazhong Univ Sci Technolog Med Sci; 2012 Apr; 32(2):265-271. PubMed ID: 22528232
[TBL] [Abstract][Full Text] [Related]
7. Effects of WIN55,212-2 on voltage-gated sodium channels in trigeminal ganglion neurons of rats.
Fu H; Xiao JM; Cao XH; Ming ZY; Liu LJ
Neurol Res; 2008 Feb; 30(1):85-91. PubMed ID: 17767805
[TBL] [Abstract][Full Text] [Related]
8. Cannabinoid WIN 55,212-2 inhibits TRPV1 in trigeminal ganglion neurons via PKA and PKC pathways.
Wang W; Cao X; Liu C; Liu L
Neurol Sci; 2012 Feb; 33(1):79-85. PubMed ID: 21584737
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of GABAergic neurotransmission in the ventral tegmental area by cannabinoids.
Szabo B; Siemes S; Wallmichrath I
Eur J Neurosci; 2002 Jun; 15(12):2057-61. PubMed ID: 12099913
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the in vivo receptor occupancy for the behavioral effects of cannabinoids using a radiolabeled cannabinoid receptor agonist, R-[125/131I]AM2233.
Dhawan J; Deng H; Gatley SJ; Makriyannis A; Akinfeleye T; Bruneus M; Dimaio AA; Gifford AN
Synapse; 2006 Aug; 60(2):93-101. PubMed ID: 16715483
[TBL] [Abstract][Full Text] [Related]
11. Cannabinoid CB1 and CB2 receptors differentially modulate L- and T-type Ca
Qian WJ; Yin N; Gao F; Miao Y; Li Q; Li F; Sun XH; Yang XL; Wang Z
Neuropharmacology; 2017 Sep; 124():143-156. PubMed ID: 28431968
[TBL] [Abstract][Full Text] [Related]
12. Cannabinoid receptor-independent actions of the aminoalkylindole WIN 55,212-2 on trigeminal sensory neurons.
Price TJ; Patwardhan A; Akopian AN; Hargreaves KM; Flores CM
Br J Pharmacol; 2004 May; 142(2):257-66. PubMed ID: 15155534
[TBL] [Abstract][Full Text] [Related]
13. CB
Long J; Lei X; Chen M; Yang S; Sun T; Zeng J; Yu D; Tian H; Liu X
Neurochem Res; 2018 Feb; 43(2):267-275. PubMed ID: 29127599
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of spontaneous neurotransmission in the nucleus of solitary tract of the rat by the cannabinoid agonist WIN 55212-2 is not via CB1 or CB2 receptors.
Accorsi-Mendonça D; Almado CE; Dagostin AL; Machado BH; Leão RM
Brain Res; 2008 Mar; 1200():1-9. PubMed ID: 18308297
[TBL] [Abstract][Full Text] [Related]
15. The agonists for nociceptors are ubiquitous, but the modulators are specific: P2X receptors in the sensory neurons are modulated by cannabinoids.
Krishtal O; Lozovaya N; Fedorenko A; Savelyev I; Chizhmakov I
Pflugers Arch; 2006 Dec; 453(3):353-60. PubMed ID: 16741755
[TBL] [Abstract][Full Text] [Related]
16. Stimulation of cannabinoid (CB1) and prostanoid (EP2) receptors opens BKCa channels and relaxes ocular trabecular meshwork.
Stumpff F; Boxberger M; Krauss A; Rosenthal R; Meissner S; Choritz L; Wiederholt M; Thieme H
Exp Eye Res; 2005 May; 80(5):697-708. PubMed ID: 15862177
[TBL] [Abstract][Full Text] [Related]
17. Cannabinoids inhibit noradrenergic and purinergic sympathetic cotransmission in the rat isolated mesenteric arterial bed.
Pakdeechote P; Dunn WR; Ralevic V
Br J Pharmacol; 2007 Nov; 152(5):725-33. PubMed ID: 17641668
[TBL] [Abstract][Full Text] [Related]
18. Cannabinoid receptor agonists modulate calcium channels in rat retinal Müller cells.
Yang W; Li Q; Wang SY; Gao F; Qian WJ; Li F; Ji M; Sun XH; Miao Y; Wang Z
Neuroscience; 2016 Jan; 313():213-24. PubMed ID: 26621126
[TBL] [Abstract][Full Text] [Related]
19. Cannabinoids produce neuroprotection by reducing intracellular calcium release from ryanodine-sensitive stores.
Zhuang SY; Bridges D; Grigorenko E; McCloud S; Boon A; Hampson RE; Deadwyler SA
Neuropharmacology; 2005 Jun; 48(8):1086-96. PubMed ID: 15910885
[TBL] [Abstract][Full Text] [Related]
20. Cannabinoids decrease the K(+) M-current in hippocampal CA1 neurons.
Schweitzer P
J Neurosci; 2000 Jan; 20(1):51-8. PubMed ID: 10627580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
